cabozantinib,atezolizumab
roche
['contact-03', 'milestone,(-milestones)']
 presenting the results of the phase iii contact-03 trial - first ever p3 rct to evaluate the efficacy/safety of pdl1 inh. after prior anti-pd1/pdl1 treatment a major milestone to better understand ici response #asco23 
Incoming PGY-1 @BIDMC_IM | Postdoctoral GU Oncology Research Fellow @DanaFarber | MD, Class of 2020 @USJLiban | Interested in Oncology